Utah Medical Products Inc
UTMDFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Utah Medical Products Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 15 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 29, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| BARCLAYS PLC | 2026-03-31 | 1,092 | Not shown | SEC filing |
| True Wealth Design, LLC | 2026-03-31 | 30 | Not shown | SEC filing |
| Invesco Ltd. | 2026-03-31 | 4,117 | Not shown | SEC filing |
| ROTHSCHILD INVESTMENT LLC | 2026-03-31 | 1 | Not shown | SEC filing |
| EVERETT HARRIS & CO /CA/ | 2026-03-31 | 25,564 | Not shown | SEC filing |
| Bridge City Capital, LLC | 2026-03-31 | 7,291 | Not shown | SEC filing |
| BANK OF AMERICA CORP /DE/ | 2026-03-31 | 4,773 | Not shown | SEC filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2026-03-31 | 9,838 | Not shown | SEC filing |
| Covestor Ltd | 2026-03-31 | 152 | Not shown | SEC filing |
| US BANCORP \DE\ | 2026-03-31 | 414 | Not shown | SEC filing |
| RITHOLTZ WEALTH MANAGEMENT | 2026-03-31 | 14,807 | Not shown | SEC filing |
| Bare Financial Services, Inc | 2026-03-31 | 26 | Not shown | SEC filing |
| SEIZERT CAPITAL PARTNERS, LLC | 2026-03-31 | 5,436 | Not shown | SEC filing |
| HARBOR CAPITAL ADVISORS, INC. | 2026-03-31 | 178 | Not shown | SEC filing |
| ENVESTNET ASSET MANAGEMENT INC | 2026-03-31 | 10,080 | Not shown | SEC filing |
| UBS Group AG | 2026-03-31 | 36,916 | Not shown | SEC filing |
| Copeland Capital Management, LLC | 2026-03-31 | 1,059 | Not shown | SEC filing |
| Sanctuary Advisors, LLC | 2026-03-31 | 3,628 | Not shown | SEC filing |
| JPL Wealth Management, LLC | 2026-03-31 | 46 | Not shown | SEC filing |
| Focus Partners Wealth | 2026-03-31 | 4,898 | Not shown | SEC filing |
- Each value is checked against Utah Medical Products Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- EverSource Wealth Advisors, LLC: 62 shares reported 2025-12-31; 34 shares reported 2026-03-31.
- Versant Capital Management, Inc: 440 shares reported 2025-12-31; 446 shares reported 2026-03-31.
- ENVESTNET ASSET MANAGEMENT INC: 6,611 shares reported 2025-12-31; 10,080 shares reported 2026-03-31.
- Covestor Ltd: 18 shares reported 2025-12-31; 152 shares reported 2026-03-31.
112 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Utah Medical Products Inc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2021-11-24 · HOYER ERNST G: Larger than 133 of the 143 other insider sales of Common Stock on file. SEC filing
- 2020-06-03 · CORNWELL KEVIN L: Larger than 134 of the 143 other insider sales of Common Stock on file. SEC filing
- 2018-06-15 · CORNWELL KEVIN L: Larger than 140 of the 143 other insider sales of Common Stock on file. SEC filing
- 2018-06-05 · CORNWELL KEVIN L: Larger than 138 of the 143 other insider sales of Common Stock on file. SEC filing
- 2018-05-18 · HOYER ERNST G: Larger than 142 of the 143 other insider sales of Common Stock on file. SEC filing
- 2018-03-08 · CORNWELL KEVIN L: Larger than 131 of the 143 other insider sales of Common Stock on file. SEC filing
- 2018-02-15 · HOYER ERNST G: Larger than 136 of the 143 other insider sales of Common Stock on file. SEC filing
- 2016-12-08 · CORNWELL KEVIN L: Larger than 132 of the 143 other insider sales of Common Stock on file. SEC filing
- 2013-08-30 · HOYER ERNST G: Larger than 141 of the 143 other insider sales of Common Stock on file. SEC filing
- 2013-08-23 · CORNWELL KEVIN L: Larger than 129 of the 143 other insider sales of Common Stock on file. SEC filing
- 2013-07-30 · CORNWELL KEVIN L: Larger than 134 of the 143 other insider sales of Common Stock on file. SEC filing
- 2012-12-10 · HOYER ERNST G: Larger than 139 of the 143 other insider sales of Common Stock on file. SEC filing
- 2009-12-09 · CORNWELL KEVIN L: Larger than 130 of the 143 other insider sales of Common Stock on file. SEC filing
- 2009-12-07 · CORNWELL KEVIN L: Larger than 137 of the 143 other insider sales of Common Stock on file. SEC filing
- 2009-11-16 · CORNWELL KEVIN L: Larger than all 143 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2023-05-18 | RICHINS PAUL O · Director | Common Stock | S — Open market or private sale | −700 | 93.47 | SEC filing |
| 2022-11-18 | RICHINS PAUL O · Director | Common Stock | S — Open market or private sale | −449 | 90.81 | SEC filing |
| 2022-11-17 | RICHINS PAUL O · Director | Common Stock | S — Open market or private sale | −161 | 90.00 | SEC filing |
| 2022-11-11 | RICHINS PAUL O · Director | Common Stock | S — Open market or private sale | −40 | 92.50 | SEC filing |
| 2022-05-11 | PAYNE BARBARA A · Director | Common Stock | S — Open market or private sale | −2,000 | 85.20 | SEC filing |
| 2021-11-24 | HOYER ERNST G · Director | Common Stock | S — Open market or private sale | −4,900 | 126.41 | SEC filing |
| 2021-11-23 | HOYER ERNST G · Director | Common Stock | S — Open market or private sale | −100 | 125.01 | SEC filing |
| 2021-11-18 | PAYNE BARBARA A · Director | Common Stock | S — Open market or private sale | −1,249 | 111.06 | SEC filing |
Showing 8 of 14 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-28 | Koopman Brian · Principal Financial Officer | Common Stock | G — Bona fide gift | −50 | SEC filing |
| 2025-10-31 | Koopman Brian · Principal Financial Officer | Employee Stock Option - Right to Buy | A — Grant, award, or other acquisition | +500 | SEC filing |
| 2025-09-04 | Koopman Brian · Principal Financial Officer | Common Stock | G — Bona fide gift | −50 | SEC filing |
| 2025-08-25 | RICHINS PAUL O · Director | Common Stock | G — Bona fide gift | −100 | SEC filing |
| 2024-11-01 | Koopman Brian · Principal Financial Officer | Employee Stock Option - Right to Buy | A — Grant, award, or other acquisition | +500 | SEC filing |
| 2024-07-18 | Koopman Brian · Principal Financial Officer | Common Stock | G — Bona fide gift | −50 | SEC filing |
| 2024-05-17 | RICHINS PAUL O · Director | Common Stock | G — Bona fide gift | −225 | SEC filing |
| 2023-10-27 | Koopman Brian · Principal Financial Officer | Employee Stock Option - Right to Buy | A — Grant, award, or other acquisition | +500 | SEC filing |
Showing 8 of 34 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.